Molecular Genetics of Cancer Flashcards
(47 cards)
Mutations of tumor suppressors are mainly what kind of cellular component?
transcription factors
an oncogene is mutated via point mutation is usually known as a?
gain of function mutation
What is the only naturally occurring growth factor oncogene?
sis
What does sis encode for?
PDGF
Polycythemia vera and Erythroleukemia are mutations involving what receptor mutation?
gp55
HPV is inappropriately stimulated by what receptor?
E5 leading to sustained activation of PDGF receptor
Non-muscular tropomyosin is involved with what chromosomal translocation?
Trk receptor kinase
located in the cytosol after change
Many breast cancers are due to ?
HER2 gene over expression
Treatment of HER2+ breast cancer
Herceptin=only extend life expectancy by 5 mo
What induces GTP hydrolysis of the Ras?
GAP
What has the capability of activating Ras?
SOS has GEF activity
Ras then can activate the what pathway that phosphorylates what 3 things in order?
RAF>MEK>ERK
What amino acid is changed to convert Ras into an oncogene?
postion 12 amino acid to GLY=leaves RAS active
C-Src is normally activated at Tyr position at C-term 527 by?
de-phosphorylation
In Rous Sarcoma, Src has a deletion at terminal?
C-term position 18 producing v-Src and leaving it active
C-Fos and c-Myc are
transcription factors
What phase of the cell cycle does c-myc and and c-for encode genes for?
Progression through G1 and G1 to S phase
Burkitt’s lymphoma where is the c-myc gene translocated from and to where?
CH 8 to CH 14
What does the c-myc translated gene use to encode its protein products?
antibody enhancer
High expression and localized duplication of the translocated myc gene can
lead to increased expression of myc
Non-Hodkin’s Lymphoma aka
Burkitt’s lymphoma
folicular lymphoma involves
a translocation of bcl2 gene on CH 18 that fuses together with an antibody enhancer on CH 14
bcl2 in Burkitt’s lymohoma is produced by antibody enhancers causing
increase in anti-apopotosis
What would increase the cell cycle abnormally?
point mutation to a cyclin or loss of tumor supressor